ON-Q SILVER SOAKER 5IN, 400 ML/5ML/HR
Report
- Report Number
- 2026095-2012-00203
- Event Type
- Injury
- Date Received
- July 31, 2012
- Date of Event
- June 20, 2007
- Report Date
- December 11, 2009
- Manufacturer
- I-FLOW, LLC
- Product Code
- MEB
- PMA / PMN Number
- K063530
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MS, US
- Reporter Occupation
- NOT APPLICABLE
Narratives
METHOD: NO PRODUCT WAS RETURNED FOR EVAL AND INVESTIGATION. RESULT: THE INFO CONTAINED IS FROM LEGAL DOCUMENTS SERVED ON I-FLOW, LLC. THE COMPLAINT WAS OPENED SO THAT A MEDICAL DEVICE REPORT (MDR) CAN BE FILED WITH THE U.S. FOOD AND DRUG ADMINISTRATION. NO FURTHER INVESTIGATION WILL BE CONDUCTED. CONCLUSION: AS THIS COMPLAINT WAS CREATED FROM A LAWSUIT SERVED ON I-FLOW OR THE THREAT OF A LAWSUIT, NO CUSTOMER CONTACT CAN BE MADE AT THIS TIME DUE TO THE PENDING OR THREATENED LITIGATION." AS OF (B)(4) 2006, I-FLOW UPDATED THE ON-Q PUMP DIRECTIONS FOR USE (DFU), TO INCLUDE THE FOLLOWING IN THE WARNINGS SECTION: "AVOID PLACING THE CATHETER IN JOINT SPACES. ALTHOUGH THERE IS NO DEFINITIVE ESTABLISHED CAUSAL RELATIONSHIP, SOME LITERATURE HAS SHOWN A POSSIBLE ASSOCIATION BETWEEN CONTINUOUS INTRA-ARTICULAR INFUSIONS (PARTICULARLY WITH BUPIVACAINE) AND THE SUBSEQUENT DEVELOPMENT OF CHONDROLYSIS." (DFU 1307011). ON (B)(4) 2007, I-FLOW HAS ALSO PREPARED A TECHNICAL BULLETIN ENTITLED "WHAT WE KNOW ABOUT CHONDROLYSIS TODAY". (1303722, REV E).
DRUG/DILUENT: UNK, FILL VOLUME: 400 ML, FLOW RATE: 5.0 ML/HR, PROCEDURE: ARTHROSCOPY OF LEFT SHOULDER WITH SUBACROMIAL DECOMPRESSION. ARTHROSCOPY OF LEFT SHOULDER WITH DISTAL CLAVICLE EXCISION. CATHPLACE: LEFT SHOULDER. PT ALLEGES CHONDROLYSIS IN LEFT SHOULDER FOLLOWING PLACEMENT OF AN ON-Q PAINBUSTER AFTER SURGERY ON (B)(6) 2007.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ON-Q SILVER SOAKER 5IN, 400 ML/5ML/HR | ELASTOMERIC PUMP | MEB | I-FLOW, LLC | PM026-A | 722232 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 38 YR | Other |